Universityof Alabama

Birmingham, Alabama 35924

37 studies enrolling now · 368 studies all time

What they study most

ABDOMINAL AORTIC ANEURYSMS, Abruptio Placentae, Acute Aortic Dissection, Acute Coronary Syndrome, Acute Graft-versus-host Disease, Acute Ischemic Stroke, Acute Kidney Injury, Acute Kidney Injury (AKI), Acute Kidney Injury Due to Sepsis, Acute Lung Injury, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia

Studies at this site

• A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis — Recruiting now
• A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma — Recruiting now
• A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE) — Recruiting now
• A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP — Recruiting now
• Deep Functional Phenotyping of the ALA Lung Health Cohort — Recruiting now
• Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy — Recruiting now
• Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA — Recruiting now
• SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance) — Recruiting now
• Rett Syndrome Registry — Recruiting now
• Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2) — Recruiting now
• Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD) — Recruiting now
• Radiation Free Study — Recruiting now
• Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy)) — Recruiting now
• Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study — Recruiting now
• A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN) — Recruiting now
• Diagnostic and Therapeutic Applications in Microarrays in Organ Transplantation — Recruiting now
• Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD — Recruiting now
• A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756) — Recruiting now
• American Lung Association (ALA) Lung Health Cohort — Recruiting now
• Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT) — Recruiting now
• TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd — Recruiting now
• Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials — Recruiting now
• Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma — Recruiting now
• DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors — Recruiting now
• Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma — Recruiting now
• Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight Infants — Recruiting now
• "Prapela® SVS Incubator Pad for Apnea of Prematurity — Recruiting now
• US National OCS Liver Perfusion (OLP) Registry — Recruiting now
• Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort — Recruiting now
• Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes — Running, not enrolling
• Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study — Enrolling by invitation
• A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation. — Starting soon
• Managed Access Program for Del-zota in Participants With DMD Mutations Amenable to Exon 44 Skipping — Available (expanded access)
• Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (CLEAR-AKI) — Completed
• Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function — Running, not enrolling
• A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors — Running, not enrolling
• Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations — Running, not enrolling
• Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study — Completed
• A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity. — Completed
• Roflumilast or Azithromycin to Prevent COPD Exacerbations Trial — Completed
• A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency — Completed
• Safety and Effectiveness of the KOKO Device to Treat Primary Abnormal Postpartum Uterine Bleeding or Hemorrhage — Running, not enrolling
• Risk Underlying Rural Areas Longitudinal Cohort Study (RURAL) Heart and Lung Study — Running, not enrolling
• Phase 2 Study of Rapcabtagene Autoleucel in Myositis — Running, not enrolling
• Delayed Cord Clamping in VLBW Infants — Completed
• Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With PL — Running, not enrolling
• Timing of Sodium Intake and Nocturnal Sodium Excretion and Blood Pressure in Obese African Americans — Completed
• A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer — Stopped early
• Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone — Completed
• Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis — Running, not enrolling